Literature DB >> 9470826

A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.

A J Croockewit1, M H Bronchud, M S Aapro, M J Bargetzi, J Crown, A Gratwohl, W Lange, H Ludwig, G Martinelli, R Mertelsmann, V Nuessler, R Willemze, T J De Witte, R Zittoun, H Zwierzina.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9470826     DOI： 10.1016/s0959-8049(97)00222-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

Review 1.  Management of febrile neutropenia in low risk cancer patients.

Authors:  B A Oppenheim; H Anderson
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

2.  A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia.

Authors:  Y Lalami; M Paesmans; M Aoun; R Munoz-Bermeo; K Reuss; S Cherifi; C G Alexopoulos; J Klastersky
Journal:  Support Care Cancer       Date:  2004-10       Impact factor: 3.603
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.